Journal article
Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II)
Clinical pharmacokinetics, Vol.22(4), pp.274-283
04/1992
DOI: 10.2165/00003088-199222040-00003
PMID: 1606787
Abstract
Positron emission tomography (PET) involves imaging the biodistribution and tissue localisation of small amounts of radiolabelled biomolecules or drugs. In Part I of this article, which appeared in the previous issue of the Journal, the applications of pharmacokinetics in PET were discussed in order to derive quantitative measures of physiological function. Part II examines the use of PET imaging as a tool to study the pharmacokinetics and pharmacodynamics of specific drugs.
Details
- Title: Subtitle
- Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II)
- Creators
- Laura L Boles PontoJames A Ponto
- Resource Type
- Journal article
- Publication Details
- Clinical pharmacokinetics, Vol.22(4), pp.274-283
- DOI
- 10.2165/00003088-199222040-00003
- PMID
- 1606787
- ISSN
- 0312-5963
- eISSN
- 1179-1926
- Language
- English
- Date published
- 04/1992
- Academic Unit
- Radiology; Pharmaceutical Sciences and Experimental Therapeutics; Pharmacy Practice and Science
- Record Identifier
- 9984051701602771
Metrics
18 Record Views